Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

SkinCeuticals Announces The Launch Of A New Corrective Serum

Posted on: 28 Feb 18

NEW YORK, Feb. 26, 2018 /PRNewswire/ -- SkinCeuticals, a leader in advanced skincare technology, announces the launch of Discoloration Defense. This new corrective serum is a high-potency serum for key types of discoloration.

Everyday elements including UV exposure, prescription drugs, and some professional treatments, can trigger the production of excess melanin in the skin's lowest, unseen epidermal layers. This excess melanin rises to the surface of the skin causing visible and often stubborn discoloration such as post-acne marks and brown patches.

A first-to-market treatment, Discoloration Defense is formulated to target multiple stages of discoloration with the latest generation of discoloration-fighting ingredients, including tranexamic acid. New studies show that topical formulations with tranexamic acid have a documented effect on discoloration including difficult-to-treat forms such as stubborn brown patches and post-acne marks. The formula boasts a high concentration of four breakthrough ingredients:

3% Tranexamic Acid helps to minimize the appearance of discoloration and brown patches with continued use

5% Niacinamide helps reduce the appearance of discoloration

5% HEPES accelerates cell turnover

1% Kojic Acid improves skin brightness

As a brand committed to scientific research and clinical results, the trials conducted on Discoloration Defense by SkinCeuticals and its independent partners demonstrate its effectiveness on skin. In a 12-week study with clinical evaluations made by an expert evaluator, the combination of Discoloration Defense's key ingredients resulted in:

60% average reduction in the appearance of stubborn brown patches

59% average reduction in discoloration

81% average reduction in post-acne marks

59% improvement in overall skin tone

"Hyperpigmentation is the fastest growing global skincare concern, and, through our wide network of partner physicians, we have seen the demand for pigmentation correction products increase significantly over the past few years," says Christina Fair, Head of US SkinCeuticals. "With this increase in popularity, we sought to deliver a product that could both complement the results of professional discoloration treatments, such as chemical peels, and work effectively on its own. We are thrilled to be able to offer Discoloration Defense as an effective solution to visible pigmentation our consumers are seeking to correct."

As part of an at-home regimen, Discoloration Defense can be paired with an antioxidant, broad spectrum UVA/UVB sunscreen and other moisturizers in the SkinCeuticals corrective portfolio to tackle multiple anti-aging concerns. Visit to locate a dermatologist nearby who can recommend the combination best for individual skin types and concerns.

SkinCeuticals Discoloration Defense is available for $98 at, as well as select dermatologist offices nationwide.

Founded in Dallas, TX in 1997, SkinCeuticals discovers, develops and delivers an advanced line of scientifically backed cosmeceutical treatments.  As leaders in antioxidant and sun protection technology, SkinCeuticals products have been shown to improve skin health by protecting skin from environmental damage and visibly improving skin clarity, tone, and texture to minimize the appearance of fine lines and wrinkles. For more information, visit the brand on Facebook, Twitter or Instagram, or at

Contact:  Alyssa Keller at Alison Brod Marketing + Communications: (212) 230-1800 /  
Laura Cummins at SkinCeuticals: (212) 984-4907/

Editor's Details

Mike Wood

Last updated on: 28/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.